CDKN2B-AS1 and type 2 diabetes mellitus: Expression profiles of lncRNAs in PBMCs from patients with T2D highlighted how several lncRNAs were significantly increased compared to controls, and these included HOTAIR, Meg3, LET, MALAT1, MIAT, CDKN2BAS1/ANRIL, XIST, PANDA, GAS5, Linc‐p21, ENST00000550337.1, PLUTO, and NBR2.192